Skip to content
The Nexus
DossierENTITY

GLP-1 resistance

Coverage of GLP-1 resistance in the Nexus archive.

Earliest in view: Apr 12 · 12:58 UTCMost recent: Jun 5 · 15:13 UTC
Co-mentioned in this coverage
genetic variantstopic1GLP-1 drugstopic1Type 2 diabetestopic1blood sugar targetstopic1Ozempictopic1Wegovytopic1Genetic variantstopic1Diabetestopic1Weight-losstopic1
Recent coverage
  • HEALTHJun 5 · 15:13 UTCSCIENCE DAILY
    Scientists discover why ozempic may not work for some people

    Scientists have identified genetic variants that may reduce the effectiveness of GLP-1 drugs for treating Type 2 diabetes in about 10% of the population. These variants appear to cause 'GLP-1 resistance,' making carriers less likely to achieve healthy blood sugar targets during clinical trials of these medications.

  • HEALTHApr 12 · 12:58 UTCSCIENCE DAILY
    Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason

    A new study identifies that 10% of people may not respond to Ozempic and Wegovy due to genetic variants causing GLP-1 resistance. The condition involves elevated GLP-1 hormone levels without proper response to the drugs.